
About Atilus Pharma
Atilus Pharma is a Healthcare company based in Mumbai (India). It operates as an API manufacturing and supply in the healthcare sector from Mumbai, India. The company has 1 employees. Its Indian entity Atilus Pharma Private Limited reported revenue of βΉ8.68 Cr. Atilus Pharma offers products and services including Biotin Pharma Grade and Hydroquinone. Its focus areas include Pharmaceuticals, API Manufacturing, Therapeutic Ingredients and Chemicals.
Company details
Atilus Pharma is identified as a manufacturer of Active Pharmaceutical Ingredients that caters to global markets, including generic and custom requirements for recognized brands. It is headquartered in Mumbai, India, and is accredited with GMP, ISO 9001-2015, Halal, and Kosher standards. Products are developed across therapeutic categories such as Psychiatric and Dermatology through research and quality checks. The company is noted for its commitment to quality and timely delivery in more than 25 countries, ensuring high standards in healthcare services without boundaries.
- Headquarters Mumbai, India
- Employees 1
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Social LinkedIn
- Legal Name Atilus Pharma Pvt Ltd
- Date of Incorporation 19 Aug, 2020
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹8.68 Cr
FY 2025 · -20% YoY
- Net Profit₹72.3 Lakh
FY 2025 · 8% margin
- EBITDA₹1.07 Cr
FY 2025 · 12% margin
- Employee Count1
Associated legal entities of Atilus Pharma
Atilus Pharma operates through Atilus Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Atilus Pharma Private Limited CIN U24110MH2020PTC344095 | Active | 19 Aug 2020 | Mumbai, Maharashtra | ₹8.7 Cr | – | 2 | View details |
Products & Services of Atilus Pharma
Atilus Pharma offers a comprehensive portfolio of products and services, including Biotin Pharma Grade and Hydroquinone.
Biotin Pharma Grade is produced for pharmaceutical applications across therapy areas
Hydroquinone is manufactured for use in dermatology and other therapeutic segments
Board of directors of Atilus Pharma Private Limited (Atilus Pharma)
Atilus Pharma Private Limited is the primary company behind Atilus Pharma. The board of Atilus Pharma Private Limited currently have 2 directors; the longest-serving is Lomesh Vinod Shah, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Lomesh Vinod Shah DIN 08839964 | Director | 19 Aug 2020 | 6 yrs 1 mo | Atilus Pharma Private Limited |
| Niraj Vinod Shah DIN 08839965 | Director | 19 Aug 2020 | 6 yrs 1 mo | Atilus Pharma Private Limited |
Financials of Atilus Pharma
Figures of Atilus Pharma Private Limited, the primary company behind Atilus Pharma, for FY 2025. Revenue was ₹8.68 Cr (-20% year on year). Net profit was ₹72.3 Lakh (8% margin). EBITDA was ₹1.07 Cr (12% margin). Revenue has grown at a compounded annual rate of -1% over three years.
- ₹8.68 CrRevenue · FY 2025 · -20% YoY
- ₹72.3 LakhNet profit · 8% margin
- ₹1.07 CrEBITDA · 12% margin
- ₹1 LakhPaid-up capital
- -1%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Atilus Pharma Private Limited are on its company page.
Detailed financial statements for Atilus Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Atilus Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Atilus Pharma
Atilus Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Atilus Pharma has 1 employees.
The primary company behind Atilus Pharma, Atilus Pharma Private Limited, reported revenue of βΉ8.68 Cr for FY 2025, down 20% year on year.
Atilus Pharma is identified as a manufacturer of Active Pharmaceutical Ingredients that caters to global markets, including generic and custom requirements for recognized brands. It is headquartered in Mumbai, India, and is accredited with GMP, ISO 9001-2015, Halal, and Kosher standards. Products are developed across therapeutic categories such as Psychiatric and Dermatology through research and quality checks. The company is noted for its commitment to quality and timely delivery in more than 25 countries, ensuring high standards in healthcare services without boundaries.
Atilus Pharma offers Biotin Pharma Grade and Hydroquinone.
Atilus Pharma operates through Atilus Pharma Private Limited.
The legal entities of Atilus Pharma currently have 2 directors, including Lomesh Vinod Shah, Niraj Vinod Shah.